Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Post
Print
Michael Powell
Senior Scientist
AstraZeneca
Poster(s):
(907) Low dosage of a novel SARS-COV-2 mRNA-VLP vaccine elicits equivalent cell-mediated immunity to a licensed mRNA vaccine
Friday, April 17, 2026
11:30 AM - 12:30 PM
US ET
